Veracyte, Inc.
USD47.80
-0.38 (-0.79%)
CEO
Marc A. Stapley
IPO Date
2013-10-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$48.17
Prev. Close
$48.18
Day Low
$46.36
Day High
$48.17
52W Low
$22.61
52W High
$50.71
Market Cap
$3.81B
Volume
1.34M
| 24,000 |
| $45.40 |
| 27 May 2026 | Wygant Jonathan | VP, Chief Accounting Officer | M-Exempt | Disposed | 24,000 | $24.80 |
| 22 May 2026 | EPSTEIN ROBERT S | director | S-Sale | Disposed | 10,000 | $44.01 |
| 8 May 2026 | McGuire Annie | SVP, General Counsel | S-Sale | Disposed | 5,102 | $38.05 |
| 8 May 2026 | McGuire Annie | SVP, General Counsel | S-Sale | Disposed | 5,102 | $40.00 |
| 14 Apr 2026 | Haas Kevin Richard | Chief Dev and Tech Officer | A-Award | Acquired | 44,221 | $0.00 |
| 25 Mar 2026 | Haas Kevin Richard | officer | Disposed | 0 | $0.00 |
| 10 Mar 2026 | Wygant Jonathan | VP, Chief Accounting Officer | A-Award | Acquired | 10,525 | $0.00 |
| 10 Mar 2026 | McGuire Annie | SVP, General Counsel | A-Award | Acquired | 32,892 | $0.00 |
| $1,001 - $15,000 |
| 11 Nov 2023 | Josh Gottheimer | Josh Gottheimer | Purchase | $1,001 - $15,000 |
| 15 Oct 2023 | Josh Gottheimer | Josh Gottheimer | Sale | $1,001 - $15,000 |
| 19 May 2023 | Daniel Goldman | Daniel Goldman | Sale | $1,001 - $15,000 |
| 11 Jan 2021 | Gilbert Cisneros | Gilbert Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 11 Jan 2021 | Gilbert Cisneros | Gilbert Cisneros | Sale (Partial) | $1,001 - $15,000 |
| 7 Jan 2021 | Josh Gottheimer | Josh Gottheimer | Sale (Partial) | $1,001 - $15,000 |
| 5 Nov 2020 | Gilbert Cisneros | Gilbert Cisneros | Sale (Partial) | $1,001 - $15,000 |